Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients
Clinical trial NCT05858684 · RECRUITING
Trial details
- NCT number
- NCT05858684
- Sponsor
- RenJi Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-11
- Primary completion
- 2028-08-10
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.